IP
CTSO icon

Intellectus Partners’s Cytosorbents Corp CTSO Stock Holding History

Intellectus Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$13K – 304
2018
Q3 		$13K Hold
1,000
– – ﹤0.01% 453
2018
Q2 		$11K Hold
1,000
– – ﹤0.01% 463
2018
Q1 		$7K Hold
1,000
– – ﹤0.01% 504
2017
Q4 		$7K Buy
+1,000
New +$6.36K ﹤0.01% 515

Other funds holding CTSO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Intellectus Partners's CTSO Position: Q4 2018 in Review

Intellectus Partners sold out of Cytosorbents Corp (CTSO) in Q4 2018, closing a stake of 1,000 shares — an estimated $13K sold.

Intellectus Partners first reported a position in CTSO in Q4 2017 and held it in 4 quarters. The position peaked at $13K in Q3 2018. 85 funds tracked by Wall St. Rank hold CTSO as of Q4 2018.

  • Intellectus Partners reported no remaining Cytosorbents Corp position as of Q4 2018 after selling out during the quarter.
  • Intellectus Partners sold 1,000 Cytosorbents Corp shares in Q4 2018, an estimated $13K.
  • Intellectus Partners first reported a position in Cytosorbents Corp in Q4 2017 and held it in 4 quarters.
  • Intellectus Partners's Cytosorbents Corp position peaked at $13K in Q3 2018.
  • 85 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.